论文信息 - P15.03 A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC - 字舞流文

P15.03 A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC

A. Roshak | R. Knoblauch | T. Hida | N. Haddish-Berhane | John Xie | Y. Inoh | A. Yamashita | Y. Botilde | K. Goto | R. Iwasawa | N. Funami | Y. Ohe | S. Mita